BrainsWay Ltd. BWAY Stock
BrainsWay Ltd. Price Chart
BrainsWay Ltd. BWAY Financial and Trading Overview
| BrainsWay Ltd. stock price | 14.04 USD |
| Previous Close | 15.89 USD |
| Open | 15.43 USD |
| Bid | 10.93 USD x 200 |
| Ask | 19.23 USD x 200 |
| Day's Range | 15.05 - 15.57 USD |
| 52 Week Range | 5.01 - 17.35 USD |
| Volume | 154.27K USD |
| Avg. Volume | 165.8K USD |
| Market Cap | 618.95M USD |
| Beta (5Y Monthly) | 0.219 |
| PE Ratio (TTM) | 70.181816 |
| EPS (TTM) | 0.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.67 USD |
BWAY Valuation Measures
| Enterprise Value | 554.54M USD |
| Trailing P/E | 70.181816 |
| Forward P/E | 33.085476 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.009472 |
| Price/Book (mrq) | 7.7744207 |
| Enterprise Value/Revenue | 9.864 |
| Enterprise Value/EBITDA | 83.818 |
Trading Information
BrainsWay Ltd. Stock Price History
| Beta (5Y Monthly) | 0.219 |
| 52-Week Change | 210.95% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 17.35 USD |
| 52 Week Low | 5.01 USD |
| 50-Day Moving Average | 15.09 USD |
| 200-Day Moving Average | 10.82 USD |
BWAY Share Statistics
| Avg. Volume (3 month) | 165.8K USD |
| Avg. Daily Volume (10-Days) | 140.75K USD |
| Shares Outstanding | 40.09M |
| Float | 26.58M |
| Short Ratio | 0.9 |
| % Held by Insiders | 6.03% |
| % Held by Institutions | 29.92% |
| Shares Short | 131.88K |
| Short % of Float | 0.42% |
| Short % of Shares Outstanding | 0.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 15.57% |
| Operating Margin (ttm) | 12.91% |
| Gross Margin | 75.50% |
| EBITDA Margin | 11.76% |
Management Effectiveness
| Return on Assets (ttm) | 3.30% |
| Return on Equity (ttm) | 12.55% |
Income Statement
| Revenue (ttm) | 56.22M USD |
| Revenue Per Share (ttm) | 1.47 USD |
| Quarterly Revenue Growth (yoy) | 34.59% |
| Gross Profit (ttm) | 42.45M USD |
| EBITDA | 6.62M USD |
| Net Income Avi to Common (ttm) | 8.76M USD |
| Diluted EPS (ttm) | 0.22 |
| Quarterly Earnings Growth (yoy) | 106.89% |
Balance Sheet
| Total Cash (mrq) | 58.64M USD |
| Total Cash Per Share (mrq) | 1.54 USD |
| Total Debt (mrq) | 6.71M USD |
| Total Debt/Equity (mrq) | 8.85 USD |
| Current Ratio (mrq) | 3.338 |
| Book Value Per Share (mrq) | 1.986 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.65M USD |
| Levered Free Cash Flow (ttm) | 3.03M USD |
Profile of BrainsWay Ltd.
| Country | United States |
| State | N/A |
| City | Jerusalem |
| Address | 16 Hartum St |
| ZIP | 9777516 |
| Phone | 972 2 582 4030 |
| Website | https://www.brainsway.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 129 |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Q&A For BrainsWay Ltd. Stock
What is a current BWAY stock price?
BrainsWay Ltd. BWAY stock price today per share is 14.04 USD.
How to purchase BrainsWay Ltd. stock?
You can buy BWAY shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BrainsWay Ltd.?
The stock symbol or ticker of BrainsWay Ltd. is BWAY.
Which industry does the BrainsWay Ltd. company belong to?
The BrainsWay Ltd. industry is Medical Devices.
How many shares does BrainsWay Ltd. have in circulation?
The max supply of BrainsWay Ltd. shares is 40.09M.
What is BrainsWay Ltd. Price to Earnings Ratio (PE Ratio)?
BrainsWay Ltd. PE Ratio is 63.81818000 now.
What was BrainsWay Ltd. earnings per share over the trailing 12 months (TTM)?
BrainsWay Ltd. EPS is 0.22 USD over the trailing 12 months.
Which sector does the BrainsWay Ltd. company belong to?
The BrainsWay Ltd. sector is Healthcare.
BrainsWay Ltd. BWAY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}